Orencia clickject 125 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FFL1G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,511
Award facts
- Contract value 100% obligated
- $9,510.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,510.54 delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of January 22, 2026, executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems.
This delivery order represents a task order issued against AmerisourceBergen's comprehensive $999,999,999 IDC with DLA Troop Support Medical (designated SPE2DX), which runs through December 2026 and functions as a global pharmaceutical support vehicle. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including deliveries to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The non-competitive nature of this delivery order reflects AmerisourceBergen's established position as a prime vendor within the DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FFL1G?
SPE2DR26FFL1G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FFL1G worth?
The government has obligated $9,511 on SPE2DR26FFL1G.
Is contract SPE2DR26FFL1G an order under another contract?
Yes. SPE2DR26FFL1G is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL1G competed?
The extent of competition for SPE2DR26FFL1G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award